The sustainable packaging company relocates its branded foam production to a more expansive Lansing site, boosting capacity, efficiency, and support for growing demand the life science markets.
TemperPack, who specializes in sustainable thermal packaging, has relocated its Green Cell Foam production plant from Holt, MI to a larger 135,000 square-foot facility in Lansing.1 The new site not only welcomes expansion, but features boosts in equipment and an increase in operational efficiency.
Specifically, the move represents a 60% boost in manufacturing space, which allows the company to further tackle demand for its branded insulation products.
Located near key interstate corridors, the facility offers improved connectivity for freight carriers and regional partners, reinforcing TemperPack’s capacity to support a growing customer base with greater efficiency. The site is also equipped with upgraded manufacturing systems, expanded IT capabilities, and a larger number of shipping and receiving bays.
“As we continue to grow and uphold our commitment to sustainability, expanding our Michigan operations allows us to better meet rising customer demand for Green Cell Foam,” notedTroy Hagenbuch, TemperPack’s COO. “This new facility significantly enhances our manufacturing and service capabilities, enabling us to deliver greater efficiency, speed, and reliability to our customers.”
Essentially, TemperPack's goal is to offer environmentally friendly alternatives to one’s traditional packaging materials. In this case, Green Cell Foam is a plant-based, certified compostable insulation material that reduces environmental impact and offers performance that’s compare to polystyrene foam, often known as EPS.
“As direct-to-consumer e-commerce continues to expand in food and beverage, and life sciences, due to significant trends in ‘Food is Health’ and ‘Preventive Medicine,’ TemperPack must keep pace with the demand for sustainable packaging solutions that provide exceptional unboxing experiences for our customers’ consumers, built on a digital thread for innovative end-to-end solutions that build brand and community with a personalized and sustainable experience,” said Peter Wells, CEO.
DTC—also known as direct-to-patient (DTP)—is continuing to gain popularity within the greater pharma supply chain. In fact, according to Thani Jambulingam, PhD, professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business, pharma’s push into DTP sales is reshaping the front end of drug distribution, but wholesalers remain indispensable as the backbone of the industry’s regulated, specialty, and logistics infrastructure.2
“There are thousands and thousands of products getting distributed. We are talking about a handful of products that are going through DTP program,” he explained. “And even there, the DTP program can take the prescription and ship the prescription, but somewhere, it has to be stored. Somewhere it has to have the cold chain in place. Somebody has to keep all the regulatory requirements fulfilled. Somebody has to bill, somebody has to pay for it. All these, and then looking for supply changes and looking for other compliance requirements, somebody has to do it.
“I don't think pharma companies by themselves have that capability to do that. We have a resource that has the capability of doing all this very effectively and efficiently. How can that be dispensed? I mean, how can we be without it? My point is that you might take a few functions out of the supply process. The rest of it has to be done, and who else can do it like the wholesalers?”
References
1. TemperPack Expands Manufacturing Capabilities in Michigan. Business Wire. December 16, 2025. Accessed January 2, 2026.
2. Saraceno N. Trade & Channel Strategies 2025: Why Wholesalers Remain Pharma’s Backbone. Pharmaceutical Commerce. December 23, 2025. Accessed January 2, 2026.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
